Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Angiogenesis, angiogenic factor expression and hematological malignancies.

D Ribatti1, A Vacca, G De Falco

  • 1Department of Human Anatomy and Histology, and University of Bari Medical School, Italy. ribatti@anatomia.uniba.it

Anticancer Research
|March 23, 2002
PubMed
Summary

Angiogenesis, the formation of new blood vessels, is crucial for the progression of hematological malignancies like multiple myeloma. Targeting this process may offer new treatments for blood cancers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Surviving adversity: Exploring the presence of Lunularia cruciata (L.) Dum. on metal-polluted mining waste.

Plant biology (Stuttgart, Germany)·2024
Same author

Three is better than two: humoral response in allogeneic HSCT after the third BNT162b2 SARS-CoV-2 mRNA vaccine.

European review for medical and pharmacological sciences·2023
Same author

Pulmonary Embolism in COVID-19 Patients Is Not Related to a Deterioration of Tissue Oxygenation.

Advances in experimental medicine and biology·2022
Same author

Cardiovascular Risk Score and Pulmonary Gas Exchange in COVID-19 Patients Show No Correlation.

Advances in experimental medicine and biology·2022
Same author

Chronic graft vs. host disease and hypogammaglobulinemia predict a lower immunological response to the BNT162b2 mRNA COVID-19 vaccine after allogeneic hematopoietic stem cell transplantation.

European review for medical and pharmacological sciences·2022
Same author

Development of pectoral muscle atrophy in critically ill patients.

Medicina intensiva·2022

Area of Science:

  • Hematology
  • Oncology
  • Vascular Biology

Background:

  • Solid tumor growth involves avascular and vascular phases.
  • Angiogenesis is increasingly recognized as critical in hematological malignancy progression.
  • Progression from monoclonal gammopathy of undetermined significance (MGUS) to multiple myeloma (MM) involves plasma cell-induced angiogenesis.

Purpose of the Study:

  • To review the role of angiogenesis in the progression of hematological malignancies.
  • To highlight the link between enhanced neovascularization and disease progression in various blood cancers.
  • To explore the potential of anti-angiogenic therapies in managing hematological tumors.

Main Methods:

  • Review of existing literature on angiogenesis in hematological malignancies.

Related Experiment Videos

  • Analysis of studies examining neovascularization in multiple myeloma, acute lymphoblastic leukemia, and B-cell non-Hodgkin's lymphomas.
  • Discussion of the implications of angiogenic and proteolytic potential of plasma cells.

    • Main Results:

    • Enhanced bone marrow neovascularization is observed in active multiple myeloma and acute untreated lymphoblastic leukemia.
    • Angiogenesis is significantly enhanced in relation to disease progression in B-cell non-Hodgkin's lymphomas.
    • Increased angiogenic and proteolytic potential of plasma cells contributes to extramedullary spread in MM.

    Conclusions:

    • Angiogenesis plays a critical role in the progression of hematological malignancies.
    • Enhanced bone marrow neovascularization is a hallmark of several advanced blood cancers.
    • Angiostatic agents, such as thalidomide, represent a potential therapeutic strategy for hematological tumors.